Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Autoimmune Disease Diagnosis Market Expected To Expand Between 2025 And 2029?
The autoimmune disease diagnosis market size has shown robust growth in recent years. It is projected to expand from $5.84 billion in 2024 to $6.2 billion in 2025, at a compound annual growth rate (CAGR) of 6.2%. The expansion during the historic period can be ascribed to the increasing incidence of autoimmune diseases, the development of emerging markets, greater healthcare expenditure, and a high prevalence in women.
The autoimmune disease diagnosis market size is projected to experience substantial growth in the coming years, with an anticipated increase to $8.65 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is primarily driven by factors such as enhanced funding for autoimmune (AI) diagnostics, accelerated economic growth, increasing awareness of autoimmune diseases, and the ongoing discovery of biomarkers. Prominent trends expected in this period include forging alliances with other market participants, making investments in artificial intelligence companies, collaborating with government agencies, and developing at-home rapid test kits.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp
What Are The Key Drivers Of Growth In The Autoimmune Disease Diagnosis Market?
The prevalence of autoimmune diseases has spurred expansion within the autoimmune disease diagnosis market. As an illustration, data from February 2023, released by Multiple Sclerosis Australia, an Australian national non-profit organization focused on research and advocacy for individuals affected by multiple sclerosis, indicated that 33,335 Multiple Sclerosis patients were present in Australia in 2021. This represented a 30% (7,728) rise compared to the prior four years, which had 25,607 patients. Consequently, the global rise in autoimmune disease occurrences is fueling the expansion of the autoimmune disease diagnosis market.
What Are The Leading Segments Analyzed In The Autoimmune Disease Diagnosis Market?
The autoimmune disease diagnosismarket covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments
2) By End User: Clinical Laboratories, Hospitals, Others
3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
Subsegments:
1) By Consumables And Assay Kits: ELISA Kits; Reagents And Test Kits; Sample Collection And Preservation Devices; Control And Calibration Materials
2) By Instruments: Immunoassay Analyzers; Flow Cytometers; Luminometers; Microscopes; Other Diagnostic Devices
What Are The Latest Industry Trends Transforming The Autoimmune Disease Diagnosis Market?
In the autoimmune disease diagnosis market, biosensors and nano biosensors for swift detection serve as an innovative instrument for identifying antibodies. They are greatly preferred owing to their cost-effectiveness, superior sensitivity, straightforward operation, multiplexing capabilities, and quick diagnostic output. Apart from assessing the quantity of antibodies in human blood serum with exceptional sensitivity, this technology also measures antibody activity, as the analytical method employs portable optical label-free biosensors founded on spectral correlation interferometry. This point-of-care solution delivers a more holistic, revealing, prompt, and accurate diagnosis for autoimmune conditions when contrasted with conventional approaches.
Which Leading Companies Dominate The Autoimmune Disease Diagnosis Market Share?
Major companies operating in the autoimmune disease diagnosis market include Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc., bioMérieux SA, SQI Diagnostics, SCHILLER Healthcare India Pvt. Ltd, Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smith’s Medical India Pvt Ltd, Agappe Diagnostics Ltd, Accord Medical Products Private Limited, Lepu Medical Technology Company (Beijing) Co., Ltd, Yuwell – Jiangsu Yuyue Medical Equipment & Supply Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Sanofi, Themis Bioscience, Becton Dickinson and Company
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Which Region Currently Holds The Largest Share Of The Autoimmune Disease Diagnosis Market?
North America was the largest region in the autoimmune disease diagnosis market in 2024. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Autoimmune Disease Diagnosis Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3231&type=smp
Browse Through More Reports Similar to the Global Autoimmune Disease Diagnosis Market 2025, By The Business Research Company
Hematology Analyzers And Reagents Global Market Report 2025
Hematology Diagnostic Devices And Equipment Global Market Report 2025
Hemostasis Diagnostic Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model